Steve M. Sabus

SVP & Chief Commercial Officer, Turning Point Therapeutics, Inc.

Companies

Syndax Pharmaceuticals IncChief Commercial Officer Dec 5, 2022 to Dec 5, 2022¹
Turning Point Therapeutics, Inc.SVP & Chief Commercial Officer Jun 1, 2022 to Aug 17, 2022²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSyndax Pharmaceuticals Inc, Chief Commercial Officer
2
SEC EDGARTurning Point Therapeutics, Inc., SVP & Chief Commercial Officer